BioCentury
ARTICLE | Company News

DFH Pharma deal

April 23, 2012 7:00 AM UTC

DFH and NIH's National Institute of Allergy and Infectious Diseases (NIAID) partnered to develop second generation HIV maturation inhibitor drugs. Under a material evaluation agreement, DFH and NIAID'...